These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 25775093)
1. Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient. Kobus K; Hartl D; Ott CE; Osswald M; Huebner A; von der Hagen M; Emmerich D; Kühnisch J; Morreau H; Hes FJ; Mautner VF; Harder A; Tinschert S; Mundlos S; Kolanczyk M PLoS One; 2015; 10(3):e0119030. PubMed ID: 25775093 [TBL] [Abstract][Full Text] [Related]
2. Neurofibromin inactivation impairs osteocyte development in Nf1Prx1 and Nf1Col1 mouse models. Kühnisch J; Seto J; Lange C; Stumpp S; Kobus K; Grohmann J; Elefteriou F; Fratzl P; Mundlos S; Kolanczyk M Bone; 2014 Sep; 66():155-62. PubMed ID: 24947449 [TBL] [Abstract][Full Text] [Related]
3. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I. Gutmann DH; Cole JL; Stone WJ; Ponder BA; Collins FS Genes Chromosomes Cancer; 1994 May; 10(1):55-8. PubMed ID: 7519874 [TBL] [Abstract][Full Text] [Related]
4. Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin. Kolanczyk M; Kühnisch J; Kossler N; Osswald M; Stumpp S; Thurisch B; Kornak U; Mundlos S BMC Med; 2008 Jul; 6():21. PubMed ID: 18671844 [TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis 1: closing the GAP between mice and men. Dasgupta B; Gutmann DH Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431 [TBL] [Abstract][Full Text] [Related]
6. Dietary intervention rescues myopathy associated with neurofibromatosis type 1. Summers MA; Rupasinghe T; Vasiljevski ER; Evesson FJ; Mikulec K; Peacock L; Quinlan KG; Cooper ST; Roessner U; Stevenson DA; Little DG; Schindeler A Hum Mol Genet; 2018 Feb; 27(4):577-588. PubMed ID: 29228356 [TBL] [Abstract][Full Text] [Related]
7. NF1 is a critical regulator of muscle development and metabolism. Sullivan K; El-Hoss J; Quinlan KG; Deo N; Garton F; Seto JT; Gdalevitch M; Turner N; Cooney GJ; Kolanczyk M; North KN; Little DG; Schindeler A Hum Mol Genet; 2014 Mar; 23(5):1250-9. PubMed ID: 24163128 [TBL] [Abstract][Full Text] [Related]
8. Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse. Summers MA; Vasiljevski ER; Mikulec K; Peacock L; Little DG; Schindeler A Mol Genet Metab; 2018 Apr; 123(4):518-525. PubMed ID: 29477258 [TBL] [Abstract][Full Text] [Related]
10. Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. Hegedus B; Yeh TH; Lee DY; Emnett RJ; Li J; Gutmann DH Hum Mol Genet; 2008 Oct; 17(19):2956-66. PubMed ID: 18614544 [TBL] [Abstract][Full Text] [Related]
11. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. Steinemann D; Arning L; Praulich I; Stuhrmann M; Hasle H; Stary J; Schlegelberger B; Niemeyer CM; Flotho C Haematologica; 2010 Feb; 95(2):320-3. PubMed ID: 20015894 [TBL] [Abstract][Full Text] [Related]
12. Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1). O'Donohue AK; Li XC; Lee LR; Vasiljevski ER; Little DG; Munns CF; Schindeler A PLoS One; 2024; 19(6):e0304778. PubMed ID: 38913608 [TBL] [Abstract][Full Text] [Related]
13. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice. Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460 [TBL] [Abstract][Full Text] [Related]
14. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR. Rübben A; Bausch B; Nikkels A Mol Cancer; 2006 Sep; 5():36. PubMed ID: 16961930 [TBL] [Abstract][Full Text] [Related]
15. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning. Anastasaki C; Woo AS; Messiaen LM; Gutmann DH Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518 [TBL] [Abstract][Full Text] [Related]
16. Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity. Deraredj Nadim W; Chaumont-Dubel S; Madouri F; Cobret L; De Tauzia ML; Zajdel P; Bénédetti H; Marin P; Morisset-Lopez S Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12310-12315. PubMed ID: 27791021 [TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Gottfried ON; Viskochil DH; Couldwell WT Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723 [TBL] [Abstract][Full Text] [Related]
18. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease. Kimura N; Watanabe T; Fukase M; Wakita A; Noshiro T; Kimura I Mod Pathol; 2002 Mar; 15(3):183-8. PubMed ID: 11904334 [TBL] [Abstract][Full Text] [Related]